What is the Open FDA Initiative?
In June 2014, the U.S. FDA launched the “open FDA” a technology-driven initiative to make government information easily accessible to the public. The initiative was initially an order from the White House to implement a new digital strategy to not only make data accessible but easy to interpret as well. This arrangement focused on creating Application Program Interfaces (API) that would allow developers to access data from various agencies and integrate them into new, easy-to-use software.
Is it successful?
Since then the OpenFDA initiative has achieved great success over the year because of its engagement with the developer community through GitHub, StackExchange and Twitter and prioritizing data based on public interest. According to Kass-Hout, FDA’s Chief Health Informatics Officer, more than 20,000 unique IP addresses have connected to the openFDA. and site has more than 6,000 registered API users.
Why is this beneficial?
- Open FDA will make publicly available data accessible and in a structured, computer-readable format.
- Software developers can now build their own applications that can perform quick searches and extract large amounts of public information instantaneously.
- All data can be pulled out of the FDA database in real-time
RegDesk is an A.I.-powered regulatory intelligence software that offers 24/7 access to the latest regulatory information for over 50 markets worldwide. Our platform eliminates the need for medical device companies to spend months gathering intelligence and preparing their registration applications. Through RegDesk’s centralized platform, clients can get access to product-specific registration requirements, expert answers to their most critical regulatory questions, and real-time alerts about global regulatory changes. To experience the power of RegDesk, contact us at email@example.com or visit www.regdesk.co.